XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

170 hedge funds and large institutions have $1.98B invested in Acceleron Pharma Inc. in 2018 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 60 increasing their positions, 38 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
170
Holders Change
+20
Holders Change %
+13.33%
% of All Funds
3.9%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.14%
New
34
Increased
60
Reduced
38
Closed
14
Calls
$32.5M
Puts
$64.4M
Net Calls
-$31.8M
Net Calls Change
-$24.9M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$59.8M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$208M
3
DM
3
Deerfield Management
New York
$54.7M
4
Fidelity International
4
Fidelity International
Bermuda
$21M
5
GPP
5
Great Point Partners
Connecticut
$36.8M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$214M
2
Westfield Capital Management
2
Westfield Capital Management
Massachusetts
$38.6M
3
NHAS
3
Novo Holdings A/S
Denmark
$53.6M
4
EAM
4
Eagle Asset Management
Florida
$43.1M
5
CTA
5
Carillon Tower Advisers
Florida
$31.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
SM
176
Sabby Management
Florida
– -$338K -8,646 Closed
TI
177
Trexquant Investment
Connecticut
– -$324K -8,292 Closed
Jane Street
178
Jane Street
New York
– -$250K -6,404 Closed
AIM
179
Assured Investment Management
New York
– -$95K -2,419 Closed
TRCT
180
Tower Research Capital (TRC)
New York
– -$59K -1,500 Closed
NIT
181
NumerixS Investment Technologies
British Columbia, Canada
– -$39K -1,000 Closed
APP
182
Avantax Planning Partners
Iowa
– -$3K -74 Closed
4 5 6 7
8